BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20073064)

  • 1. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
    Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
    Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
    Rosendahl AH; Forsberg G
    Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice.
    Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8687-92. PubMed ID: 15173588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
    Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
    Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma.
    Miyajima A; Asano T; Seta K; Asano T; Kakoi N; Hayakawa M
    Urology; 2003 May; 61(5):1072-7. PubMed ID: 12736050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of expression of transforming growth factor-beta type II receptor in murine renal cell carcinoma (renca) cells by 5-Aza-2'-deoxycytidine.
    Zhang Q; Rubenstein JN; Liu VC; Park I; Jang T; Lee C
    Life Sci; 2005 Jan; 76(10):1159-66. PubMed ID: 15620579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
    Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
    Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
    Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
    Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HILI inhibits TGF-β signaling by interacting with Hsp90 and promoting TβR degradation.
    Zhang K; Lu Y; Yang P; Li C; Sun H; Tao D; Liu Y; Zhang S; Ma Y
    PLoS One; 2012; 7(7):e41973. PubMed ID: 22848678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
    Fukuchi M; Fukai Y; Masuda N; Miyazaki T; Nakajima M; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Cancer Res; 2002 Dec; 62(24):7162-5. PubMed ID: 12499250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation.
    Tan R; Zhang J; Tan X; Zhang X; Yang J; Liu Y
    J Am Soc Nephrol; 2006 Oct; 17(10):2781-91. PubMed ID: 16959829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Smad ubiquitin regulatory factor 2 suppresses transforming growth factor-β mediated liver fibrosis.
    Cai Y; Zhou CH; Fu D; Shen XZ
    J Dig Dis; 2012 Jun; 13(6):327-34. PubMed ID: 22624557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.